Asensus Surgical, Inc. Provides Revenue Guidance for the Fourth Quarter and Year Ended December 31, 2021
For the full year, preliminary unaudited 2021 revenue is expected to be approximately $7.9 million to $8.3 million, representing revenues from the sale of three Senhance Systems, system leasing, and related revenues from instruments and accessories, and services.